In a retrospective study of 133 patients with PD-L1-unselected stage IIIB-IV NSCLC treated with PD-1 inhibitors, NLR was shown to be an independent prognostic factor for PFS [16]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.